|
Market Closed -
Other stock markets
|
After hours 01:48:57 pm | |||
| 33.38 EUR | -0.71% |
|
33.38 | -0.01% |
| Dec. 04 | Evotec's Partner Bayer Starts Mid-stage Study of Genetic Kidney Disease Drug | MT |
| Dec. 04 | Bayer Starts Phase IIa Study for Treatment of Patients with Alport Syndrome | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.33% | 1.61% | 78.63x | 1x | 1.42x | 6.79x | 12.24x | 38.47B | ||
| 0.58% | 0.66% | 44.35x | 33.4x | 14.69x | 32.6x | 35.01x | 908B | ||
| 2.55% | 2.64% | 19.32x | 6.21x | 5.42x | 15.01x | 16.47x | 488B | ||
| 2.85% | 2.97% | 53.42x | -552.17x | 7.55x | 17.89x | 18.41x | 404B | ||
| 3.19% | 3.25% | 17.98x | 6.42x | 4.53x | 11.35x | 12.88x | 331B | ||
| 1.79% | 1.88% | 27.19x | 6.14x | 5.15x | 15.26x | 16.08x | 280B | ||
| 3.07% | 3.19% | 18.4x | 5.77x | 4.98x | 11.7x | 12.6x | 256B | ||
| 3.21% | 3.35% | 13.04x | 4.65x | 4.26x | 9.1x | 10.27x | 250B | ||
| 3.81% | 3.78% | 13.25x | 7.24x | 4.74x | 9.83x | 11.36x | 212B | ||
| 2.81% | 2.97% | 25.99x | 20.55x | 6.27x | 10.77x | 14.39x | 183B | ||
| 2.7% | 2.82% | 17.89x | 6.71x | 5.64x | 10.32x | 12.41x | 152B | ||
| 6.64% | 6.77% | 13.31x | 1.61x | 2.99x | 7.51x | 8.65x | 146B | ||
| 4.92% | 5.07% | 12.3x | 1.31x | 2.65x | 8.61x | 9.58x | 120B | ||
| -.--% | -.--% | 29.45x | 6.22x | 8.92x | 19.27x | 20.02x | 116B | ||
| 4.76% | 4.9% | 12.27x | 5.34x | 2.9x | 8.42x | 8.78x | 106B | ||
| 3.56% | 3.82% | 13.04x | 5.11x | 2.69x | 7.95x | 9.11x | 97.85B | ||
| 3% | 1.53% | 32.54x | 7.08x | 10.5x | 20.56x | 21.98x | 90.09B | ||
| -.--% | -.--% | 203.57x | 73.51x | 15.99x | 105.6x | 102.22x | 61.48B | ||
| 0.45% | 0.52% | 46.17x | 6.87x | 11.14x | 36.6x | 38.49x | 57.56B | ||
| Average | 2.64% | 2.72% | 36.43x | -18.27x | 6.44x | 19.22x | 20.58x | 226.24B | |
| Weighted average by Cap. | 2.45% | 2.52% | 31.10x | -39.38x | 7.52x | 18.57x | 20.07x |
- Stock Market
- Equities
- BAYN Stock
- Sector Bayer AG
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















